Clinical development of passive tau-based immunotherapeutics for treating primary and secondary tauopathies.
Expert Opin Investig Drugs
; 32(7): 625-634, 2023.
Article
in En
| MEDLINE
| ID: mdl-37405389
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Supranuclear Palsy, Progressive
/
Tauopathies
/
Alzheimer Disease
Limits:
Humans
Language:
En
Journal:
Expert Opin Investig Drugs
Journal subject:
TERAPIA POR MEDICAMENTOS
Year:
2023
Document type:
Article
Affiliation country:
Italia